Cargando…
Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites
BACKGROUND: The estimates of risk of malaria in early childhood are imprecise given the current entomologic and parasitological tools. Thus, the utility of anti-Anopheles salivary gSG6-P1 peptide antibody responses in measuring exposure to Anopheles bites during early infancy has been assessed. METH...
Autores principales: | Drame, Papa M, Poinsignon, Anne, Dechavanne, Célia, Cottrell, Gilles, Farce, Manon, Ladekpo, Rodolphe, Massougbodji, Achille, Cornélie, Sylvie, Courtin, David, Migot-Nabias, Florence, Garcia, André, Remoué, Franck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511589/ https://www.ncbi.nlm.nih.gov/pubmed/26198354 http://dx.doi.org/10.1186/s12936-015-0800-6 |
Ejemplares similares
-
Novel Peptide Marker Corresponding to Salivary Protein gSG6 Potentially Identifies Exposure to Anopheles Bites
por: Poinsignon, Anne, et al.
Publicado: (2008) -
IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal
por: Drame, Papa M, et al.
Publicado: (2012) -
Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites
por: Poinsignon, Anne, et al.
Publicado: (2009) -
gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas
por: Sagna, André Barembaye, et al.
Publicado: (2013) -
Human Antibody Responses to the Anopheles Salivary gSG6-P1 Peptide: A Novel Tool for Evaluating the Efficacy of ITNs in Malaria Vector Control
por: Drame, Papa Makhtar, et al.
Publicado: (2010)